PARKCURE — Detection of therapeutic effects of GDNF-expressing mesenchymal stem cells (Q3298506)

From EU Knowledge Graph
Revision as of 15:23, 22 January 2022 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in es, and other parts: Adding Spanish translations)
Jump to navigation Jump to search
Project Q3298506 in Germany
Language Label Description Also known as
English
PARKCURE — Detection of therapeutic effects of GDNF-expressing mesenchymal stem cells
Project Q3298506 in Germany

    Statements

    0 references
    0 references
    374,808.26 Euro
    0 references
    749,616.52 Euro
    0 references
    50.0 percent
    0 references
    1 January 2016
    0 references
    31 August 2018
    0 references
    Charité - Universitätsmedizin Berlin Campus Mitte Cecilie-Vogt-Klinik für Molekulare Neurologie
    0 references
    0 references
    0 references

    52°30'5.47"N, 13°24'9.18"E
    0 references
    10117 - Berlin
    0 references
    Erforschung einer neuen Syntheseroute zur Generierung von struktur-reinen Core-Shell-Partikeln, die für die pharmazeutische Produktion geeignet sind, sowie umfassende Charakterisierung der Partikel mit geeigneten Methoden und Validierungsexperimenten in vitro und in vivo im Tiermodell (German)
    0 references
    Research into a new synthesis route for the generation of structurally pure core shell particles suitable for pharmaceutical production as well as comprehensive characterisation of the particles using appropriate methods and validation experiments in vitro and in vivo in the animal model (English)
    24 October 2021
    0 references
    Recherche d’une nouvelle voie de synthèse pour la génération de particules de coquille de base de structure pure, adaptées à la production pharmaceutique, et caractérisation complète des particules par des méthodes et des expériences de validation appropriées in vitro et in vivo dans le modèle animal (French)
    6 December 2021
    0 references
    Onderzoek naar een nieuwe syntheseroute voor het genereren van structureel zuivere kernschildeeltjes die geschikt zijn voor farmaceutische productie, alsmede een uitgebreide karakterisering van de deeltjes met behulp van geschikte methoden en validatie-experimenten in vitro en in vivo in het diermodel (Dutch)
    19 December 2021
    0 references
    Ricerca di una nuova via di sintesi per la generazione di particelle strutturalmente pure del guscio del nucleo adatto alla produzione farmaceutica e caratterizzazione completa delle particelle utilizzando metodi appropriati e esperimenti di convalida in vitro e in vivo nel modello animale (Italian)
    18 January 2022
    0 references
    Investigación de una nueva vía de síntesis para la generación de partículas de núcleo estructuralmente puras adecuadas para la producción farmacéutica, así como una caracterización completa de las partículas utilizando métodos adecuados y experimentos de validación in vitro e in vivo en el modelo animal (Spanish)
    22 January 2022
    0 references

    Identifiers

    DE_TEMPORARY_1309
    0 references